nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonordefrin—Epinephrine—Dipivefrin—glaucoma	0.179	0.427	CrCrCtD
Levonordefrin—Salbutamol—Carteolol—glaucoma	0.12	0.287	CrCrCtD
Levonordefrin—Salbutamol—Levobunolol—glaucoma	0.12	0.287	CrCrCtD
Levonordefrin—ADRA2C—Brimonidine—glaucoma	0.057	0.0991	CbGbCtD
Levonordefrin—ADRA2C—Apraclonidine—glaucoma	0.057	0.0991	CbGbCtD
Levonordefrin—ADRA2B—Apraclonidine—glaucoma	0.0541	0.094	CbGbCtD
Levonordefrin—ADRA2B—Brimonidine—glaucoma	0.0541	0.094	CbGbCtD
Levonordefrin—ADRA2C—Dipivefrin—glaucoma	0.0456	0.0792	CbGbCtD
Levonordefrin—ADRA2B—Dipivefrin—glaucoma	0.0432	0.0752	CbGbCtD
Levonordefrin—ADRA2A—Apraclonidine—glaucoma	0.0376	0.0654	CbGbCtD
Levonordefrin—ADRA2A—Brimonidine—glaucoma	0.0376	0.0654	CbGbCtD
Levonordefrin—ADRA1A—Apraclonidine—glaucoma	0.0361	0.0627	CbGbCtD
Levonordefrin—ADRA2A—Dipivefrin—glaucoma	0.0301	0.0523	CbGbCtD
Levonordefrin—ADRA1A—Dipivefrin—glaucoma	0.0288	0.0501	CbGbCtD
Levonordefrin—ADRA2C—Clonidine—glaucoma	0.0237	0.0412	CbGbCtD
Levonordefrin—ADRA2B—Clonidine—glaucoma	0.0225	0.039	CbGbCtD
Levonordefrin—SLC6A2—Clonidine—glaucoma	0.0173	0.0301	CbGbCtD
Levonordefrin—ADRA2A—Clonidine—glaucoma	0.0156	0.0272	CbGbCtD
Levonordefrin—ADRA1A—Clonidine—glaucoma	0.015	0.026	CbGbCtD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	4.78e-05	0.00801	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	4.69e-05	0.00785	CbGpPWpGaD
Levonordefrin—ADRA1A—Endothelin Pathways—NOS3—glaucoma	4.52e-05	0.00757	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.52e-05	0.00756	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	4.44e-05	0.00744	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	4.3e-05	0.00721	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	4.22e-05	0.00706	CbGpPWpGaD
Levonordefrin—SLC6A2—Monoamine Transport—TNF—glaucoma	4.17e-05	0.00699	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	4.1e-05	0.00686	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	4e-05	0.0067	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC4A4—glaucoma	3.85e-05	0.00645	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—OPN4—glaucoma	3.82e-05	0.0064	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	3.81e-05	0.00637	CbGpPWpGaD
Levonordefrin—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—glaucoma	3.7e-05	0.0062	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	3.69e-05	0.00618	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—OPN4—glaucoma	3.57e-05	0.00598	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—PTGFR—glaucoma	3.44e-05	0.00576	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	3.43e-05	0.00574	CbGpPWpGaD
Levonordefrin—SLC6A2—NRF2 pathway—GSTM1—glaucoma	3.25e-05	0.00545	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—PTGFR—glaucoma	3.21e-05	0.00538	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—OPN4—glaucoma	3.12e-05	0.00522	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—OPN4—glaucoma	2.9e-05	0.00485	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—TGFB2—glaucoma	2.88e-05	0.00483	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—PTGFR—glaucoma	2.81e-05	0.0047	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—TGFB2—glaucoma	2.69e-05	0.00451	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—PTGFR—glaucoma	2.61e-05	0.00437	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.57e-05	0.0043	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NARFL—glaucoma	2.46e-05	0.00412	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CA5A—glaucoma	2.46e-05	0.00412	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—TGFB2—glaucoma	2.19e-05	0.00366	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—SOD1—glaucoma	2.19e-05	0.00366	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—OPN4—glaucoma	2.16e-05	0.00361	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—SOD1—glaucoma	2.04e-05	0.00342	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—OPN4—glaucoma	2.02e-05	0.00338	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NARFL—glaucoma	2e-05	0.00335	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CA5A—glaucoma	2e-05	0.00335	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—OPN4—glaucoma	1.96e-05	0.00328	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—PTGFR—glaucoma	1.94e-05	0.00325	CbGpPWpGaD
Levonordefrin—SLC6A2—Transmembrane transport of small molecules—SLC6A1—glaucoma	1.88e-05	0.00315	CbGpPWpGaD
Levonordefrin—ADRA1A—G alpha (q) signalling events—EDN1—glaucoma	1.85e-05	0.0031	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—OPN4—glaucoma	1.83e-05	0.00307	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—PTGFR—glaucoma	1.82e-05	0.00304	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—PTGFR—glaucoma	1.77e-05	0.00296	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—OPN4—glaucoma	1.76e-05	0.00295	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—SMO—glaucoma	1.73e-05	0.0029	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—LRP12—glaucoma	1.67e-05	0.0028	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—SOD1—glaucoma	1.66e-05	0.00278	CbGpPWpGaD
Levonordefrin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	1.66e-05	0.00277	CbGpPWpGaD
Levonordefrin—ADRA2B—G alpha (i) signalling events—C3—glaucoma	1.65e-05	0.00276	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—PTGFR—glaucoma	1.65e-05	0.00276	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—OPN4—glaucoma	1.64e-05	0.00274	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—SMO—glaucoma	1.62e-05	0.00271	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—OPN4—glaucoma	1.6e-05	0.00268	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—PTGFR—glaucoma	1.59e-05	0.00266	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—LRP12—glaucoma	1.56e-05	0.00261	CbGpPWpGaD
Levonordefrin—ADRA2C—G alpha (i) signalling events—C3—glaucoma	1.54e-05	0.00258	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—FN1—glaucoma	1.52e-05	0.00255	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.5e-05	0.00251	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—OPN4—glaucoma	1.49e-05	0.00249	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TGFB2—glaucoma	1.49e-05	0.00249	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—PTGFR—glaucoma	1.47e-05	0.00247	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—PTGFR—glaucoma	1.44e-05	0.00241	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—FN1—glaucoma	1.42e-05	0.00238	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—SMO—glaucoma	1.42e-05	0.00237	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.4e-05	0.00235	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TGFB2—glaucoma	1.39e-05	0.00233	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—LRP12—glaucoma	1.36e-05	0.00228	CbGpPWpGaD
Levonordefrin—ADRA1A—AMPK Signaling—TP53—glaucoma	1.36e-05	0.00228	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—PTGFR—glaucoma	1.34e-05	0.00224	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—SMO—glaucoma	1.32e-05	0.0022	CbGpPWpGaD
Levonordefrin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.31e-05	0.0022	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—LRP12—glaucoma	1.27e-05	0.00212	CbGpPWpGaD
Levonordefrin—ADRA2A—G alpha (i) signalling events—C3—glaucoma	1.25e-05	0.0021	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.23e-05	0.00205	CbGpPWpGaD
Levonordefrin—ADRA2C—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.23e-05	0.00205	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CA1—glaucoma	1.2e-05	0.00201	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CTSA—glaucoma	1.16e-05	0.00195	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—OPN4—glaucoma	1.16e-05	0.00194	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—FN1—glaucoma	1.15e-05	0.00193	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—EDN1—glaucoma	1.14e-05	0.00191	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	1.14e-05	0.00191	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TGFB2—glaucoma	1.13e-05	0.00189	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—SOD1—glaucoma	1.13e-05	0.00189	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CA2—glaucoma	1.1e-05	0.00184	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—OPN4—glaucoma	1.08e-05	0.00181	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HEYL—glaucoma	1.08e-05	0.0018	CbGpPWpGaD
Levonordefrin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	1.07e-05	0.00179	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—EDN1—glaucoma	1.07e-05	0.00179	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—SOD1—glaucoma	1.05e-05	0.00176	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—PTGFR—glaucoma	1.04e-05	0.00175	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HEYL—glaucoma	1.01e-05	0.00168	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR ligand binding—C3—glaucoma	9.99e-06	0.00167	CbGpPWpGaD
Levonordefrin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	9.95e-06	0.00167	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CA1—glaucoma	9.77e-06	0.00164	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—PTGFR—glaucoma	9.74e-06	0.00163	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CTSA—glaucoma	9.46e-06	0.00158	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—OPN4—glaucoma	9.46e-06	0.00158	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—EDN1—glaucoma	9.34e-06	0.00156	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR ligand binding—C3—glaucoma	9.33e-06	0.00156	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CA2—glaucoma	8.93e-06	0.0015	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—SMO—glaucoma	8.9e-06	0.00149	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HEYL—glaucoma	8.79e-06	0.00147	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—OPN4—glaucoma	8.79e-06	0.00147	CbGpPWpGaD
Levonordefrin—ADRA2B—Platelet activation, signaling and aggregation—VEGFA—glaucoma	8.71e-06	0.00146	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—EDN1—glaucoma	8.68e-06	0.00145	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—MMP1—glaucoma	8.59e-06	0.00144	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—SOD1—glaucoma	8.55e-06	0.00143	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—PTGFR—glaucoma	8.51e-06	0.00143	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—SMO—glaucoma	8.31e-06	0.00139	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—CAV1—glaucoma	8.24e-06	0.00138	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HEYL—glaucoma	8.17e-06	0.00137	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—RPTOR—glaucoma	8.16e-06	0.00137	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR ligand binding—C3—glaucoma	8.16e-06	0.00137	CbGpPWpGaD
Levonordefrin—ADRA2C—Platelet activation, signaling and aggregation—VEGFA—glaucoma	8.13e-06	0.00136	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—MMP1—glaucoma	8.03e-06	0.00134	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—PTGFR—glaucoma	7.91e-06	0.00132	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NCK2—glaucoma	7.9e-06	0.00132	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—FN1—glaucoma	7.84e-06	0.00131	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—TXN—glaucoma	7.75e-06	0.0013	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—CAV1—glaucoma	7.7e-06	0.00129	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—RPTOR—glaucoma	7.62e-06	0.00128	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR ligand binding—C3—glaucoma	7.58e-06	0.00127	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NCK2—glaucoma	7.38e-06	0.00124	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—FN1—glaucoma	7.33e-06	0.00123	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—SMO—glaucoma	7.27e-06	0.00122	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—SMO—glaucoma	6.75e-06	0.00113	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—HDAC9—glaucoma	6.72e-06	0.00113	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—RPTOR—glaucoma	6.66e-06	0.00112	CbGpPWpGaD
Levonordefrin—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—glaucoma	6.61e-06	0.00111	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—MMP1—glaucoma	6.52e-06	0.00109	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—EDN1—glaucoma	6.46e-06	0.00108	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NCK2—glaucoma	6.45e-06	0.00108	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—TXN—glaucoma	6.29e-06	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—HDAC9—glaucoma	6.28e-06	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—CAV1—glaucoma	6.25e-06	0.00105	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—NOS3—glaucoma	6.23e-06	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—RPTOR—glaucoma	6.19e-06	0.00104	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—EDN1—glaucoma	6.04e-06	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTT1—glaucoma	6.01e-06	0.00101	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NCK2—glaucoma	6e-06	0.001	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—FN1—glaucoma	5.95e-06	0.000996	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—EDN1—glaucoma	5.87e-06	0.000983	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—NOS3—glaucoma	5.82e-06	0.000974	CbGpPWpGaD
Levonordefrin—ADRA2B—GPCR downstream signaling—C3—glaucoma	5.64e-06	0.000945	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—HDAC9—glaucoma	5.49e-06	0.000919	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—EDN1—glaucoma	5.48e-06	0.000918	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—EDN1—glaucoma	5.28e-06	0.000884	CbGpPWpGaD
Levonordefrin—ADRA2C—GPCR downstream signaling—C3—glaucoma	5.27e-06	0.000883	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—SMO—glaucoma	5.26e-06	0.00088	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling by GPCR—C3—glaucoma	5.13e-06	0.000858	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—HDAC9—glaucoma	5.1e-06	0.000854	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—SMO—glaucoma	4.91e-06	0.000822	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—EDN1—glaucoma	4.9e-06	0.000821	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTT1—glaucoma	4.88e-06	0.000817	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NTRK2—glaucoma	4.81e-06	0.000805	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—EDN1—glaucoma	4.79e-06	0.000802	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling by GPCR—C3—glaucoma	4.79e-06	0.000802	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CYP1B1—glaucoma	4.79e-06	0.000802	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—ABCA1—glaucoma	4.79e-06	0.000802	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—NOS3—glaucoma	4.73e-06	0.000791	CbGpPWpGaD
Levonordefrin—ADRA1A—GPCR downstream signaling—C3—glaucoma	4.61e-06	0.000772	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NTRK2—glaucoma	4.49e-06	0.000752	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—VEGFA—glaucoma	4.49e-06	0.000752	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—EDN1—glaucoma	4.45e-06	0.000746	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—SMO—glaucoma	4.29e-06	0.000719	CbGpPWpGaD
Levonordefrin—ADRA2A—GPCR downstream signaling—C3—glaucoma	4.28e-06	0.000717	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—VEGFA—glaucoma	4.19e-06	0.000702	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling by GPCR—C3—glaucoma	4.19e-06	0.000701	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NGFR—glaucoma	4.13e-06	0.000691	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—SMO—glaucoma	3.99e-06	0.000668	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NTRK2—glaucoma	3.93e-06	0.000658	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NTRK1—glaucoma	3.92e-06	0.000656	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling by GPCR—C3—glaucoma	3.89e-06	0.000651	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—ABCA1—glaucoma	3.89e-06	0.000651	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CYP1B1—glaucoma	3.89e-06	0.000651	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NGFR—glaucoma	3.85e-06	0.000645	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—GSTM1—glaucoma	3.83e-06	0.000641	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NTRK1—glaucoma	3.66e-06	0.000613	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NTRK2—glaucoma	3.65e-06	0.000611	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CDKN2B—glaucoma	3.61e-06	0.000605	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—EDN1—glaucoma	3.47e-06	0.00058	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—VEGFA—glaucoma	3.41e-06	0.00057	CbGpPWpGaD
Levonordefrin—ADRA2B—Hemostasis—TP53—glaucoma	3.39e-06	0.000568	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—MTHFR—glaucoma	3.38e-06	0.000566	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CDKN2B—glaucoma	3.37e-06	0.000565	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NGFR—glaucoma	3.37e-06	0.000564	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—EDN1—glaucoma	3.24e-06	0.000542	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NTRK1—glaucoma	3.2e-06	0.000536	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NGF—glaucoma	3.19e-06	0.000533	CbGpPWpGaD
Levonordefrin—ADRA2C—Hemostasis—TP53—glaucoma	3.17e-06	0.00053	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—APOE—glaucoma	3.15e-06	0.000527	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NGFR—glaucoma	3.13e-06	0.000524	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—CAV1—glaucoma	3.12e-06	0.000523	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—GSTM1—glaucoma	3.11e-06	0.000521	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—C3—glaucoma	3.03e-06	0.000507	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NGF—glaucoma	2.98e-06	0.000498	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NTRK1—glaucoma	2.97e-06	0.000498	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CDKN2B—glaucoma	2.95e-06	0.000494	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—EDN1—glaucoma	2.83e-06	0.000474	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—C3—glaucoma	2.83e-06	0.000474	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—APOE—glaucoma	2.82e-06	0.000472	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CAV1—glaucoma	2.79e-06	0.000468	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—MTHFR—glaucoma	2.75e-06	0.00046	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CDKN2B—glaucoma	2.74e-06	0.000459	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—FN1—glaucoma	2.66e-06	0.000445	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—APOE—glaucoma	2.63e-06	0.000441	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—EDN1—glaucoma	2.63e-06	0.00044	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—BAD—glaucoma	2.63e-06	0.00044	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CAV1—glaucoma	2.61e-06	0.000437	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NGF—glaucoma	2.6e-06	0.000436	CbGpPWpGaD
Levonordefrin—ADRA2A—Hemostasis—TP53—glaucoma	2.57e-06	0.000431	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—APOE—glaucoma	2.56e-06	0.000428	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—CAV1—glaucoma	2.53e-06	0.000424	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—FN1—glaucoma	2.48e-06	0.000416	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—C3—glaucoma	2.47e-06	0.000414	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—BAD—glaucoma	2.45e-06	0.000411	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NGF—glaucoma	2.42e-06	0.000405	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—NOS3—glaucoma	2.36e-06	0.000395	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—APOE—glaucoma	2.3e-06	0.000385	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—C3—glaucoma	2.3e-06	0.000385	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CAV1—glaucoma	2.28e-06	0.000382	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—FN1—glaucoma	2.17e-06	0.000364	CbGpPWpGaD
Levonordefrin—ADRA2C—Metabolism—PTGS2—glaucoma	2.16e-06	0.000361	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—BAD—glaucoma	2.15e-06	0.000359	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—APOE—glaucoma	2.14e-06	0.000358	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CAV1—glaucoma	2.12e-06	0.000355	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—NOS3—glaucoma	2.11e-06	0.000354	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—FN1—glaucoma	2.02e-06	0.000338	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—BAD—glaucoma	1.99e-06	0.000334	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—NOS3—glaucoma	1.97e-06	0.00033	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—NOS3—glaucoma	1.92e-06	0.000321	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—CDKN1B—glaucoma	1.83e-06	0.000306	CbGpPWpGaD
Levonordefrin—ADRA2A—Metabolism—PTGS2—glaucoma	1.75e-06	0.000294	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—NOS3—glaucoma	1.72e-06	0.000289	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—CDKN1B—glaucoma	1.71e-06	0.000286	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—MMP9—glaucoma	1.69e-06	0.000284	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—NOS3—glaucoma	1.6e-06	0.000268	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—MMP9—glaucoma	1.58e-06	0.000265	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—VEGFA—glaucoma	1.52e-06	0.000255	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—CDKN1B—glaucoma	1.49e-06	0.00025	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—VEGFA—glaucoma	1.42e-06	0.000238	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—CDKN1B—glaucoma	1.39e-06	0.000232	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—MMP9—glaucoma	1.38e-06	0.000232	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—MMP9—glaucoma	1.29e-06	0.000215	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—VEGFA—glaucoma	1.24e-06	0.000208	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—VEGFA—glaucoma	1.15e-06	0.000193	CbGpPWpGaD
Levonordefrin—ADRA2B—Signaling Pathways—TP53—glaucoma	1.15e-06	0.000193	CbGpPWpGaD
Levonordefrin—ADRA2C—Signaling Pathways—TP53—glaucoma	1.07e-06	0.00018	CbGpPWpGaD
Levonordefrin—ADRA1A—Signaling Pathways—TP53—glaucoma	9.39e-07	0.000157	CbGpPWpGaD
Levonordefrin—ADRA2A—Signaling Pathways—TP53—glaucoma	8.72e-07	0.000146	CbGpPWpGaD
